title: [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
abstract: Several clinical syndromes caused by an obligate intracellular parasite Leishmania spp. subsumed under the term leishmaniasis. Leishmaniasis is endemic in Turkey and the neighboring countries Iran, Iraq, and Syria. Leishmania spp. causes three main clinical forms: cutaneous, mucocutaneous, and visceral disease. The clinical forms may vary by species and/or region of acquisition. Two forms are observed in Turkey; visceral leishmaniasis and cutaneous leishmaniasis. Two cases of cutaneous leishmaniasis with different treatment regimens and a case of visseral leishmaniasis associated with hemophagocytic lymphohistiocytosis are presented in this report.
authors.affiliation: Dr. Sami Ulus Kadın Doğum, Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi, Çocuk Enfeksiyon Hastalıkları Bilim Dalı, Ankara, Türkiye. turkanteke@gmail.com.
authors.forename: Türkan
authors.initials: T
authors.lastname: Aydın Teke
authors.forename: Özge
authors.initials: Ö
authors.lastname: Metin Timur
authors.forename: Zeynep Gökçe
authors.initials: ZG
authors.lastname: Gayretli Aydın
authors.forename: Nur
authors.initials: N
authors.lastname: Öz
authors.forename: Gülsüm İclal
authors.initials: Gİ
authors.lastname: Bayhan
authors.forename: Nurullah
authors.initials: N
authors.lastname: Yılmaz
authors.forename: Mesut
authors.initials: M
authors.lastname: Mungan
authors.forename: Gönül
authors.initials: G
authors.lastname: Tanır
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D007492:Iran; D007493:Iraq; D007891:Leishmania / Q000302:isolation & purification; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D014421:Turkey
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; C068538:liposomal amphotericin B; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000666:Amphotericin B